Active Biotech AB Tangible Net Worth Ratio
Active Biotech AB tangible net worth ratio. Active Biotech AB (ACTI) has a Tangible Net Worth Ratio of 99.5% as of June 2026. This metric is calculated by deducting intangible assets (Skr200.00K) from net assets (Skr37.20 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Active Biotech AB (ACTI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Active Biotech AB (2000–2025)
Tangible net worth ratio of Active Biotech AB from 2000 to 2025. This chart shows how Active Biotech AB's Tangible Net Worth Ratio has changed across 26 annual periods from 2000 to 2025. As of June 2026, the ratio stands at 99.5%, reflecting net assets of Skr37.20 Million with intangible assets of Skr200.00K SEK. See working capital to net assets of Active Biotech AB to evaluate short-term liquidity relative to the company's equity base.
Active Biotech AB Tangible Net Worth Ratio by Year (2000–2025)
Active Biotech AB tangible net worth ratio by year from 2000 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Active Biotech AB from 2000 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Active Biotech AB market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.6% | Skr55.60 Million | Skr245.00K | Skr70.20 Million | ▲ +0.3 pp |
| 2024 | 99.2% | Skr32.07 Million | Skr245.00K | Skr43.20 Million | ▲ +0.0 pp |
| 2023 | 99.2% | Skr30.67 Million | Skr245.00K | Skr44.05 Million | ▼ -0.1 pp |
| 2022 | 99.3% | Skr34.51 Million | Skr245.00K | Skr51.01 Million | ▼ -0.7 pp |
| 2021 | 100.0% | Skr46.67 Million | Skr0.00 | Skr56.80 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr22.11 Million | Skr0.00 | Skr32.16 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Skr53.78 Million | Skr0.00 | Skr66.95 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr87.92 Million | Skr0.00 | Skr302.43 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr77.68 Million | Skr0.00 | Skr303.81 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr182.56 Million | Skr0.00 | Skr412.88 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr180.60 Million | Skr0.00 | Skr449.44 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr405.31 Million | Skr0.00 | Skr722.52 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr405.41 Million | Skr0.00 | Skr767.81 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr339.92 Million | Skr0.00 | Skr696.74 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr501.99 Million | Skr0.00 | Skr858.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Skr181.76 Million | Skr0.00 | Skr503.10 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Skr188.64 Million | Skr0.00 | Skr498.50 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr163.61 Million | Skr0.00 | Skr472.95 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Skr189.57 Million | Skr0.00 | Skr489.54 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Skr60.36 Million | Skr0.00 | Skr462.40 Million | ▲ +0.0 pp |
| 2005 | 100.0% | Skr176.81 Million | Skr0.00 | Skr567.86 Million | ▲ +0.0 pp |
| 2004 | 100.0% | Skr162.30 Million | Skr0.00 | Skr312.89 Million | ▲ +0.0 pp |
| 2003 | 100.0% | Skr289.58 Million | Skr0.00 | Skr345.40 Million | ▲ +0.0 pp |
| 2002 | 100.0% | Skr380.27 Million | Skr0.00 | Skr467.50 Million | ▲ +0.0 pp |
| 2001 | 100.0% | Skr678.78 Million | Skr0.00 | Skr747.74 Million | ▲ +7.3 pp |
| 2000 | 92.7% | Skr646.03 Million | Skr47.14 Million | Skr868.95 Million | — |